Exagen Inc. Reports Strong Q2 2025 Results July 29, 2025 Carlsbad, Calif., – Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2025, and recent corporate updates. | | | | Three Months Ended June 30, | | | | Six Months Ended June 30, | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 2025 | | 2024 | | 2025 | | 2024 | | (Unaudited, in thousands, except ASP | | | | | | | | | | data) | | | | | | | | | | R ...